| Identification | Back Directory | [Name]
(1S,5R,8S)-7-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)a cetyl]amino]-3,3-dimethyl-butanoyl]-N-[1-(cyclopropylcarbamoyl)-1-oxo- pentan-2-yl]-7-azabicyclo[3.3.0]octane-8-carboxamide | [CAS]
569364-34-7 | [Synonyms]
(1S,5R,8S)-7-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)a cetyl]amino]-3,3-dimethyl-butanoyl]-N-[1-(cyclopropylcarbamoyl)-1-oxo- pentan-2-yl]-7-azabicyclo[3.3.0]octane-8-carboxamide | [Molecular Formula]
C36H53N7O6 | [MDL Number]
MFCD11616089 | [MOL File]
569364-34-7.mol |
| Hazard Information | Back Directory | [Definition]
ChEBI: Telaprevir is an oligopeptide consisting of N-(pyrazin-2-ylcarbonyl)cyclohexylalanyl, 3-methylvalyl, octahydrocyclopenta[c]pyrrole-1-carboxy, and 3-amino-N-cyclopropyl-2-oxohexanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection. It has a role as a peptidomimetic, a hepatitis C protease inhibitor and an antiviral drug. It is an oligopeptide, a member of pyrazines, a cyclopentapyrrole and a member of cyclopropanes. |
|
|